npj Precision Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2142664, encodeId=6eb6214266479, content=整整23天才分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI8LFGcj43yiaxq5w72qblCubv1OHbeMOXPZ8qmia9tibRTaI1p9YmIm1yunNCLBkKVeFELATcgTiamIg/132, createdBy=80eb93372, createdName=wfkevinhan, createdTime=Wed Jun 14 04:55:32 CST 2023, time=2023-06-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127792, encodeId=6f62212e792fb, content=审稿速度:12.0 经验分享：慢得离谱，18days了，还是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/022c136c93224a889678bf7364f6159b/0fe5bf6808824efa84ba90f6332756c0.jpg, createdBy=932f5513068, createdName=ZimoonC, createdTime=Sun Apr 23 09:25:33 CST 2023, time=2023-04-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219467, encodeId=83ab121946e7c, content=Waiting to Send Decision to Author好几天了是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0d5652219, createdName=ms8000001591821560, createdTime=Fri May 13 21:22:22 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2151705, encodeId=e90b2151e05f5, content=这个杂志是不是大家都很慢啊，已经第八天了还在under consideration，已经开始担心会被拖上个把月然后还不中……。着急毕业真心不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Mon Aug 07 23:28:08 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200465, encodeId=3f352200465d4, content=偏重的研究方向：肿瘤 经验分享：投稿三天了还是submission received状态，接一个状态更新到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Fri Apr 26 06:56:58 CST 2024, time=2024-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2179738, encodeId=65c921e9738b8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;嵌合RNA 经验分享：从投稿到接受花了6.5个月，比较慢（据说这个杂志平均8个月，我可能还算快的），修回2次，着急见刊的慎投。审稿人非常专业，提了70多条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 07 00:41:51 CST 2024, time=2024-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1077059, encodeId=260310e705973, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：乳腺癌;生信 经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Sun Dec 05 12:19:44 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113154, encodeId=8d69111315474, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007877, encodeId=2e72100e8773f, content=偏重的研究方向：肿瘤 经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Sat Aug 14 17:24:18 CST 2021, time=2021-08-14, status=1, ipAttribution=)]

2023-06-14 wfkevinhan 来自山东省

整整23天才分配编辑

40 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142664, encodeId=6eb6214266479, content=整整23天才分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI8LFGcj43yiaxq5w72qblCubv1OHbeMOXPZ8qmia9tibRTaI1p9YmIm1yunNCLBkKVeFELATcgTiamIg/132, createdBy=80eb93372, createdName=wfkevinhan, createdTime=Wed Jun 14 04:55:32 CST 2023, time=2023-06-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127792, encodeId=6f62212e792fb, content=审稿速度:12.0 经验分享：慢得离谱，18days了，还是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/022c136c93224a889678bf7364f6159b/0fe5bf6808824efa84ba90f6332756c0.jpg, createdBy=932f5513068, createdName=ZimoonC, createdTime=Sun Apr 23 09:25:33 CST 2023, time=2023-04-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219467, encodeId=83ab121946e7c, content=Waiting to Send Decision to Author好几天了是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0d5652219, createdName=ms8000001591821560, createdTime=Fri May 13 21:22:22 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2151705, encodeId=e90b2151e05f5, content=这个杂志是不是大家都很慢啊，已经第八天了还在under consideration，已经开始担心会被拖上个把月然后还不中……。着急毕业真心不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Mon Aug 07 23:28:08 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200465, encodeId=3f352200465d4, content=偏重的研究方向：肿瘤 经验分享：投稿三天了还是submission received状态，接一个状态更新到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Fri Apr 26 06:56:58 CST 2024, time=2024-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2179738, encodeId=65c921e9738b8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;嵌合RNA 经验分享：从投稿到接受花了6.5个月，比较慢（据说这个杂志平均8个月，我可能还算快的），修回2次，着急见刊的慎投。审稿人非常专业，提了70多条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 07 00:41:51 CST 2024, time=2024-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1077059, encodeId=260310e705973, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：乳腺癌;生信 经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Sun Dec 05 12:19:44 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113154, encodeId=8d69111315474, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007877, encodeId=2e72100e8773f, content=偏重的研究方向：肿瘤 经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Sat Aug 14 17:24:18 CST 2021, time=2021-08-14, status=1, ipAttribution=)]

2023-04-23 ZimoonC 来自广东省

审稿速度:12.0
经验分享：慢得离谱，18days了，还是under consideration

60 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142664, encodeId=6eb6214266479, content=整整23天才分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI8LFGcj43yiaxq5w72qblCubv1OHbeMOXPZ8qmia9tibRTaI1p9YmIm1yunNCLBkKVeFELATcgTiamIg/132, createdBy=80eb93372, createdName=wfkevinhan, createdTime=Wed Jun 14 04:55:32 CST 2023, time=2023-06-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127792, encodeId=6f62212e792fb, content=审稿速度:12.0 经验分享：慢得离谱，18days了，还是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/022c136c93224a889678bf7364f6159b/0fe5bf6808824efa84ba90f6332756c0.jpg, createdBy=932f5513068, createdName=ZimoonC, createdTime=Sun Apr 23 09:25:33 CST 2023, time=2023-04-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219467, encodeId=83ab121946e7c, content=Waiting to Send Decision to Author好几天了是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0d5652219, createdName=ms8000001591821560, createdTime=Fri May 13 21:22:22 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2151705, encodeId=e90b2151e05f5, content=这个杂志是不是大家都很慢啊，已经第八天了还在under consideration，已经开始担心会被拖上个把月然后还不中……。着急毕业真心不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Mon Aug 07 23:28:08 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200465, encodeId=3f352200465d4, content=偏重的研究方向：肿瘤 经验分享：投稿三天了还是submission received状态，接一个状态更新到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Fri Apr 26 06:56:58 CST 2024, time=2024-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2179738, encodeId=65c921e9738b8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;嵌合RNA 经验分享：从投稿到接受花了6.5个月，比较慢（据说这个杂志平均8个月，我可能还算快的），修回2次，着急见刊的慎投。审稿人非常专业，提了70多条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 07 00:41:51 CST 2024, time=2024-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1077059, encodeId=260310e705973, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：乳腺癌;生信 经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Sun Dec 05 12:19:44 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113154, encodeId=8d69111315474, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007877, encodeId=2e72100e8773f, content=偏重的研究方向：肿瘤 经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Sat Aug 14 17:24:18 CST 2021, time=2021-08-14, status=1, ipAttribution=)]

2022-05-13 ms8000001591821560

Waiting to Send Decision to Author好几天了是什么情况啊

59 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142664, encodeId=6eb6214266479, content=整整23天才分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI8LFGcj43yiaxq5w72qblCubv1OHbeMOXPZ8qmia9tibRTaI1p9YmIm1yunNCLBkKVeFELATcgTiamIg/132, createdBy=80eb93372, createdName=wfkevinhan, createdTime=Wed Jun 14 04:55:32 CST 2023, time=2023-06-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127792, encodeId=6f62212e792fb, content=审稿速度:12.0 经验分享：慢得离谱，18days了，还是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/022c136c93224a889678bf7364f6159b/0fe5bf6808824efa84ba90f6332756c0.jpg, createdBy=932f5513068, createdName=ZimoonC, createdTime=Sun Apr 23 09:25:33 CST 2023, time=2023-04-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219467, encodeId=83ab121946e7c, content=Waiting to Send Decision to Author好几天了是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0d5652219, createdName=ms8000001591821560, createdTime=Fri May 13 21:22:22 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2151705, encodeId=e90b2151e05f5, content=这个杂志是不是大家都很慢啊，已经第八天了还在under consideration，已经开始担心会被拖上个把月然后还不中……。着急毕业真心不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Mon Aug 07 23:28:08 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200465, encodeId=3f352200465d4, content=偏重的研究方向：肿瘤 经验分享：投稿三天了还是submission received状态，接一个状态更新到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Fri Apr 26 06:56:58 CST 2024, time=2024-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2179738, encodeId=65c921e9738b8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;嵌合RNA 经验分享：从投稿到接受花了6.5个月，比较慢（据说这个杂志平均8个月，我可能还算快的），修回2次，着急见刊的慎投。审稿人非常专业，提了70多条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 07 00:41:51 CST 2024, time=2024-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1077059, encodeId=260310e705973, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：乳腺癌;生信 经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Sun Dec 05 12:19:44 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113154, encodeId=8d69111315474, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007877, encodeId=2e72100e8773f, content=偏重的研究方向：肿瘤 经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Sat Aug 14 17:24:18 CST 2021, time=2021-08-14, status=1, ipAttribution=)]

2023-10-28 ms8000001158768998 来自安徽省

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：人工智能;临床预测
经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。

41 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142664, encodeId=6eb6214266479, content=整整23天才分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI8LFGcj43yiaxq5w72qblCubv1OHbeMOXPZ8qmia9tibRTaI1p9YmIm1yunNCLBkKVeFELATcgTiamIg/132, createdBy=80eb93372, createdName=wfkevinhan, createdTime=Wed Jun 14 04:55:32 CST 2023, time=2023-06-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127792, encodeId=6f62212e792fb, content=审稿速度:12.0 经验分享：慢得离谱，18days了，还是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/022c136c93224a889678bf7364f6159b/0fe5bf6808824efa84ba90f6332756c0.jpg, createdBy=932f5513068, createdName=ZimoonC, createdTime=Sun Apr 23 09:25:33 CST 2023, time=2023-04-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219467, encodeId=83ab121946e7c, content=Waiting to Send Decision to Author好几天了是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0d5652219, createdName=ms8000001591821560, createdTime=Fri May 13 21:22:22 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2151705, encodeId=e90b2151e05f5, content=这个杂志是不是大家都很慢啊，已经第八天了还在under consideration，已经开始担心会被拖上个把月然后还不中……。着急毕业真心不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Mon Aug 07 23:28:08 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200465, encodeId=3f352200465d4, content=偏重的研究方向：肿瘤 经验分享：投稿三天了还是submission received状态，接一个状态更新到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Fri Apr 26 06:56:58 CST 2024, time=2024-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2179738, encodeId=65c921e9738b8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;嵌合RNA 经验分享：从投稿到接受花了6.5个月，比较慢（据说这个杂志平均8个月，我可能还算快的），修回2次，着急见刊的慎投。审稿人非常专业，提了70多条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 07 00:41:51 CST 2024, time=2024-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1077059, encodeId=260310e705973, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：乳腺癌;生信 经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Sun Dec 05 12:19:44 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113154, encodeId=8d69111315474, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007877, encodeId=2e72100e8773f, content=偏重的研究方向：肿瘤 经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Sat Aug 14 17:24:18 CST 2021, time=2021-08-14, status=1, ipAttribution=)]

2023-08-07 ms2000002007484521 来自北京

这个杂志是不是大家都很慢啊，已经第八天了还在under consideration，已经开始担心会被拖上个把月然后还不中……。着急毕业真心不建议

51 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142664, encodeId=6eb6214266479, content=整整23天才分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI8LFGcj43yiaxq5w72qblCubv1OHbeMOXPZ8qmia9tibRTaI1p9YmIm1yunNCLBkKVeFELATcgTiamIg/132, createdBy=80eb93372, createdName=wfkevinhan, createdTime=Wed Jun 14 04:55:32 CST 2023, time=2023-06-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127792, encodeId=6f62212e792fb, content=审稿速度:12.0 经验分享：慢得离谱，18days了，还是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/022c136c93224a889678bf7364f6159b/0fe5bf6808824efa84ba90f6332756c0.jpg, createdBy=932f5513068, createdName=ZimoonC, createdTime=Sun Apr 23 09:25:33 CST 2023, time=2023-04-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219467, encodeId=83ab121946e7c, content=Waiting to Send Decision to Author好几天了是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0d5652219, createdName=ms8000001591821560, createdTime=Fri May 13 21:22:22 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2151705, encodeId=e90b2151e05f5, content=这个杂志是不是大家都很慢啊，已经第八天了还在under consideration，已经开始担心会被拖上个把月然后还不中……。着急毕业真心不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Mon Aug 07 23:28:08 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200465, encodeId=3f352200465d4, content=偏重的研究方向：肿瘤 经验分享：投稿三天了还是submission received状态，接一个状态更新到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Fri Apr 26 06:56:58 CST 2024, time=2024-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2179738, encodeId=65c921e9738b8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;嵌合RNA 经验分享：从投稿到接受花了6.5个月，比较慢（据说这个杂志平均8个月，我可能还算快的），修回2次，着急见刊的慎投。审稿人非常专业，提了70多条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 07 00:41:51 CST 2024, time=2024-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1077059, encodeId=260310e705973, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：乳腺癌;生信 经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Sun Dec 05 12:19:44 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113154, encodeId=8d69111315474, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007877, encodeId=2e72100e8773f, content=偏重的研究方向：肿瘤 经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Sat Aug 14 17:24:18 CST 2021, time=2021-08-14, status=1, ipAttribution=)]

2024-04-26 ms4000000067455992 来自重庆

偏重的研究方向：肿瘤
经验分享：投稿三天了还是submission received状态，接一个状态更新到ur

6 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142664, encodeId=6eb6214266479, content=整整23天才分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI8LFGcj43yiaxq5w72qblCubv1OHbeMOXPZ8qmia9tibRTaI1p9YmIm1yunNCLBkKVeFELATcgTiamIg/132, createdBy=80eb93372, createdName=wfkevinhan, createdTime=Wed Jun 14 04:55:32 CST 2023, time=2023-06-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127792, encodeId=6f62212e792fb, content=审稿速度:12.0 经验分享：慢得离谱，18days了，还是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/022c136c93224a889678bf7364f6159b/0fe5bf6808824efa84ba90f6332756c0.jpg, createdBy=932f5513068, createdName=ZimoonC, createdTime=Sun Apr 23 09:25:33 CST 2023, time=2023-04-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219467, encodeId=83ab121946e7c, content=Waiting to Send Decision to Author好几天了是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0d5652219, createdName=ms8000001591821560, createdTime=Fri May 13 21:22:22 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2151705, encodeId=e90b2151e05f5, content=这个杂志是不是大家都很慢啊，已经第八天了还在under consideration，已经开始担心会被拖上个把月然后还不中……。着急毕业真心不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Mon Aug 07 23:28:08 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200465, encodeId=3f352200465d4, content=偏重的研究方向：肿瘤 经验分享：投稿三天了还是submission received状态，接一个状态更新到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Fri Apr 26 06:56:58 CST 2024, time=2024-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2179738, encodeId=65c921e9738b8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;嵌合RNA 经验分享：从投稿到接受花了6.5个月，比较慢（据说这个杂志平均8个月，我可能还算快的），修回2次，着急见刊的慎投。审稿人非常专业，提了70多条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 07 00:41:51 CST 2024, time=2024-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1077059, encodeId=260310e705973, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：乳腺癌;生信 经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Sun Dec 05 12:19:44 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113154, encodeId=8d69111315474, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007877, encodeId=2e72100e8773f, content=偏重的研究方向：肿瘤 经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Sat Aug 14 17:24:18 CST 2021, time=2021-08-14, status=1, ipAttribution=)]

2024-01-07 1322004234m 来自广东省

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤;嵌合RNA
经验分享：从投稿到接受花了6.5个月，比较慢（据说这个杂志平均8个月，我可能还算快的），修回2次，着急见刊的慎投。审稿人非常专业，提了70多条意见

24 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142664, encodeId=6eb6214266479, content=整整23天才分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI8LFGcj43yiaxq5w72qblCubv1OHbeMOXPZ8qmia9tibRTaI1p9YmIm1yunNCLBkKVeFELATcgTiamIg/132, createdBy=80eb93372, createdName=wfkevinhan, createdTime=Wed Jun 14 04:55:32 CST 2023, time=2023-06-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127792, encodeId=6f62212e792fb, content=审稿速度:12.0 经验分享：慢得离谱，18days了，还是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/022c136c93224a889678bf7364f6159b/0fe5bf6808824efa84ba90f6332756c0.jpg, createdBy=932f5513068, createdName=ZimoonC, createdTime=Sun Apr 23 09:25:33 CST 2023, time=2023-04-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219467, encodeId=83ab121946e7c, content=Waiting to Send Decision to Author好几天了是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0d5652219, createdName=ms8000001591821560, createdTime=Fri May 13 21:22:22 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2151705, encodeId=e90b2151e05f5, content=这个杂志是不是大家都很慢啊，已经第八天了还在under consideration，已经开始担心会被拖上个把月然后还不中……。着急毕业真心不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Mon Aug 07 23:28:08 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200465, encodeId=3f352200465d4, content=偏重的研究方向：肿瘤 经验分享：投稿三天了还是submission received状态，接一个状态更新到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Fri Apr 26 06:56:58 CST 2024, time=2024-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2179738, encodeId=65c921e9738b8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;嵌合RNA 经验分享：从投稿到接受花了6.5个月，比较慢（据说这个杂志平均8个月，我可能还算快的），修回2次，着急见刊的慎投。审稿人非常专业，提了70多条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 07 00:41:51 CST 2024, time=2024-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1077059, encodeId=260310e705973, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：乳腺癌;生信 经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Sun Dec 05 12:19:44 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113154, encodeId=8d69111315474, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007877, encodeId=2e72100e8773f, content=偏重的研究方向：肿瘤 经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Sat Aug 14 17:24:18 CST 2021, time=2021-08-14, status=1, ipAttribution=)]

2021-12-05 ms3000000303392842

审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向：乳腺癌;生信
经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。

57 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142664, encodeId=6eb6214266479, content=整整23天才分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI8LFGcj43yiaxq5w72qblCubv1OHbeMOXPZ8qmia9tibRTaI1p9YmIm1yunNCLBkKVeFELATcgTiamIg/132, createdBy=80eb93372, createdName=wfkevinhan, createdTime=Wed Jun 14 04:55:32 CST 2023, time=2023-06-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127792, encodeId=6f62212e792fb, content=审稿速度:12.0 经验分享：慢得离谱，18days了，还是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/022c136c93224a889678bf7364f6159b/0fe5bf6808824efa84ba90f6332756c0.jpg, createdBy=932f5513068, createdName=ZimoonC, createdTime=Sun Apr 23 09:25:33 CST 2023, time=2023-04-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219467, encodeId=83ab121946e7c, content=Waiting to Send Decision to Author好几天了是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0d5652219, createdName=ms8000001591821560, createdTime=Fri May 13 21:22:22 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2151705, encodeId=e90b2151e05f5, content=这个杂志是不是大家都很慢啊，已经第八天了还在under consideration，已经开始担心会被拖上个把月然后还不中……。着急毕业真心不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Mon Aug 07 23:28:08 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200465, encodeId=3f352200465d4, content=偏重的研究方向：肿瘤 经验分享：投稿三天了还是submission received状态，接一个状态更新到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Fri Apr 26 06:56:58 CST 2024, time=2024-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2179738, encodeId=65c921e9738b8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;嵌合RNA 经验分享：从投稿到接受花了6.5个月，比较慢（据说这个杂志平均8个月，我可能还算快的），修回2次，着急见刊的慎投。审稿人非常专业，提了70多条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 07 00:41:51 CST 2024, time=2024-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1077059, encodeId=260310e705973, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：乳腺癌;生信 经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Sun Dec 05 12:19:44 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113154, encodeId=8d69111315474, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007877, encodeId=2e72100e8773f, content=偏重的研究方向：肿瘤 经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Sat Aug 14 17:24:18 CST 2021, time=2021-08-14, status=1, ipAttribution=)]

2021-12-28 MS68862005

ORCIDID是什么？怎么注册？

42 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142664, encodeId=6eb6214266479, content=整整23天才分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI8LFGcj43yiaxq5w72qblCubv1OHbeMOXPZ8qmia9tibRTaI1p9YmIm1yunNCLBkKVeFELATcgTiamIg/132, createdBy=80eb93372, createdName=wfkevinhan, createdTime=Wed Jun 14 04:55:32 CST 2023, time=2023-06-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127792, encodeId=6f62212e792fb, content=审稿速度:12.0 经验分享：慢得离谱，18days了，还是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/022c136c93224a889678bf7364f6159b/0fe5bf6808824efa84ba90f6332756c0.jpg, createdBy=932f5513068, createdName=ZimoonC, createdTime=Sun Apr 23 09:25:33 CST 2023, time=2023-04-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219467, encodeId=83ab121946e7c, content=Waiting to Send Decision to Author好几天了是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0d5652219, createdName=ms8000001591821560, createdTime=Fri May 13 21:22:22 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165434, encodeId=7f9a21654341b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：人工智能;临床预测 经验分享：通过质量检查挺快的，然后状态一直是under consideration，3个多月后审稿意见回来，编辑拒稿。审稿人1是认真看了的，审稿人2根本就没认真看，说错了很多内容，挺傻的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9a98590050, createdName=ms8000001158768998, createdTime=Sat Oct 28 17:07:47 CST 2023, time=2023-10-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2151705, encodeId=e90b2151e05f5, content=这个杂志是不是大家都很慢啊，已经第八天了还在under consideration，已经开始担心会被拖上个把月然后还不中……。着急毕业真心不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Mon Aug 07 23:28:08 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200465, encodeId=3f352200465d4, content=偏重的研究方向：肿瘤 经验分享：投稿三天了还是submission received状态，接一个状态更新到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Fri Apr 26 06:56:58 CST 2024, time=2024-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2179738, encodeId=65c921e9738b8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;嵌合RNA 经验分享：从投稿到接受花了6.5个月，比较慢（据说这个杂志平均8个月，我可能还算快的），修回2次，着急见刊的慎投。审稿人非常专业，提了70多条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad3d2147763, createdName=1322004234m, createdTime=Sun Jan 07 00:41:51 CST 2024, time=2024-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1077059, encodeId=260310e705973, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：乳腺癌;生信 经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Sun Dec 05 12:19:44 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113154, encodeId=8d69111315474, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007877, encodeId=2e72100e8773f, content=偏重的研究方向：肿瘤 经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Sat Aug 14 17:24:18 CST 2021, time=2021-08-14, status=1, ipAttribution=)]

2021-08-14 ms9000000399989409

偏重的研究方向：肿瘤
经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投

45 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务